Power Law company profile

Glaukos

Biotech & Life Sciences · Aliso Viejo, United States · Founded 1998 · IPO 2015 Unicorn

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$6.67B

Market cap · Apr/2026

Revenue

$507M

Latest reported FY

Investors

11 investors on Glaukos's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 6 investors entered at this stage

DeNovo Ventures

Prism Venture Management

Borealis Ventures

Versant Ventures

Domain Associates

Frazier Healthcare Partners

Series B+ 5 investors entered at this stage

Montreux Equity Partners

Global footprint

Where Glaukos has talent and traffic

AI talent share

0.1% of workforce is AI talent
(1 of 1,062 staff)

Core AI00%

Other AI10.09%

Non-AI workforce1,06199.91%

Web traffic by country

16K monthly visits
across markets

🇺🇸 United States40%

🇯🇵 Japan16.9%

🇮🇳 India12.5%

🇨🇦 Canada10%

🇫🇷 France8.8%

Top 5 markets shown

Patent intelligence

$143M patent portfolio · 127 active families

Total estimated portfolio value via Dealroom Patent Intelligence (Patsnap), with quality scores compared against same-sector peers.

Estimated portfolio value

$143M

2.1% of market cap · 6.5× smaller than top peer Globus Medical ($930M)

127 active patent families

Where Glaukos innovates OptometryOcular implantBiomedical engineeringOphthalmologyCornea

Above peer median on Legal, Market

Quality vs same-sector peers

Glaukos on the five Patsnap quality dimensions

Glaukos in orange. Same-sector peers are the top filers by total patent value. All scores 0–100; higher is stronger.

Compare against

Patent quality scores (0–100)

Source: Dealroom Patent Intelligence · Patsnap

Tech-focus vs peers

Where Glaukos concentrates inside the peer cluster

Axes are the most-shared Patsnap topics across Glaukos and its top peers. Each polygon's reach on an axis = how prominent that topic is in that company's portfolio (#1 topic = 100, #10 = 10, absent = 0).

Compare against

Top-topic prominence (rank inverted, 0–100)

Source: Dealroom Patent Intelligence · Patsnap top-10 topics per company

This is teaser data. The full per-sub-category breakdown, individual patent records, and quality-score history are on the Dealroom platform — request a demo to access.

See Glaukos on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo